ConforMIS Inc (CFMS):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ConforMIS Inc (CFMS) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6462
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ConforMIS Inc (ConforMIS) is a medical technology company that manufactures, develops, and markets joint replacement implants. The company’s knee replacement implant products include iTotal CR a cruciate-retaining product, iTotal PS a posterior cruciate ligament substituting product, and iDuo a customized bicompartmental knee replacement system. It also provides iUni a customized unicompartmental knee replacement product, and iTotal Hip a hip replacement product candidate, among others. ConforMIS markets its products through a network of sales representatives and distributors across the US, Germany and the UK. The company operates through its manufacturing facility in Wilmington, Massachusetts. ConforMIS is headquartered in Billerica, Massachusetts, the US.

ConforMIS Inc (CFMS) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ConforMIS Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ConforMIS Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ConforMIS Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ConforMIS Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ConforMIS Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ConforMIS Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
ConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing for USD6.5 Million 10
Venture Financing 11
ConforMIS Raises US$89 Million In Series E Financing 11
Partnerships 12
ConforMIS Enters into Licensing Agreement with MicroPort Orthopedics 12
Wright Medical Group Enters into Licensing Agreement with ConforMIS 13
Equity Offering 14
ConforMIS Prices USD20 Million in Public Offering of Shares 14
ConforMIS Raises USD155.3 Million in IPO 16
ConforMIS Inc – Key Competitors 17
ConforMIS Inc – Key Employees 18
ConforMIS Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 01, 2018: Conformis Reports Second Quarter 2018 Financial Results 20
May 02, 2018: Conformis Reports First Quarter 2018 Financial Results 21
Feb 07, 2018: ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance 22
Jan 08, 2018: ConforMIS Reports Preliminary Fourth Quarter and Year-End 2017 Revenue Results; Provides 2018 Financial Guidance 24
Nov 01, 2017: ConforMIS Reports Third Quarter 2017 Financial Results 26
Aug 03, 2017: ConforMIS Reports Second Quarter 2017 Financial Results and Updates Fiscal Year 2017 Guidance 27
May 10, 2017: ConforMIS Reports First Quarter 2017 Financial Results 29
Corporate Communications 30
Aug 02, 2018: Conformis announces election of Carrie Bienkowski to its Board of Directors 30
Jul 11, 2017: ConforMIS Names Dan Krupp Senior Vice President U.S. Sales 31
Mar 31, 2017: ConforMIS Announces Election of Philip W. Johnston to its Board of Directors 32
Product News 33
Oct 16, 2017: Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants 33
Other Significant Developments 34
Sep 17, 2018: Conformis announces settlement of patent dispute with Smith & Nephew 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
ConforMIS Inc, Medical Equipment, Key Facts, 2017 2
ConforMIS Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ConforMIS Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ConforMIS Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ConforMIS Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ConforMIS Inc, Deals By Market, 2012 to YTD 2018 8
ConforMIS Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ConforMIS Acquires Machining and Polishing Assets from Broad Peak Manufacturing for USD6.5 Million 10
ConforMIS Raises US$89 Million In Series E Financing 11
ConforMIS Enters into Licensing Agreement with MicroPort Orthopedics 12
Wright Medical Group Enters into Licensing Agreement with ConforMIS 13
ConforMIS Prices USD20 Million in Public Offering of Shares 14
ConforMIS Raises USD155.3 Million in IPO 16
ConforMIS Inc, Key Competitors 17
ConforMIS Inc, Key Employees 18
ConforMIS Inc, Other Locations 19
ConforMIS Inc, Subsidiaries 19

List of Figures
ConforMIS Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ConforMIS Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ConforMIS Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ConforMIS Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ConforMIS Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ConforMIS Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ConforMIS Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ConforMIS Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ConforMIS Inc (CFMS):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flight Centre Travel Group Limited (FLT):企業の財務・戦略的SWOT分析
    Flight Centre Travel Group Limited (FLT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • British Polythene Industries Plc:企業の戦略・SWOT・財務分析
    British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • LuLu Group International:企業の戦略・SWOT・財務情報
    LuLu Group International - Strategy, SWOT and Corporate Finance Report Summary LuLu Group International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Debiopharm International SA:医療機器:M&Aディール及び事業提携情報
    Summary Debiopharm International SA (Debiopharm), a subsidiary of Debiopharm Group is a biopharmaceutical company that develops prescription drugs. The company offers a range of licensing and drug development solutions. It evaluates, searches, and in-licenses promising drug candidates for developmen …
  • SRI International:医療機器:M&Aディール及び事業提携情報
    Summary SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization’s services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It pe …
  • 1-800-FLOWERS.COM Inc (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM Inc (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Constantia Industries AG:企業の戦略的SWOT分析
    Constantia Industries AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Dare Bioscience Inc (DARE):製薬・医療:M&Aディール及び事業提携情報
    Summary Dare Bioscience Inc (Dare Bioscience), formerly Cerulean Pharma Inc, is a clinical stage biopharmaceutical company that develops products for women’s reproductive health. The company, through its dynamic tumor targeting platform, creates nanoparticle drug conjugates to attack tumor cells, re …
  • Campine NV (CAMB):企業の財務・戦略的SWOT分析
    Campine NV (CAMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • RTI Surgical Inc (RTIX)-医療機器分野:企業M&A・提携分析
    Summary RTI Surgical Inc (RTI), formerly RTI Biologics Inc is a surgical implant company that offers biologic, metal and synthetic implants. The company’s products include spine implants, surgical specialties, sports medicine implants, cardiothoracic and orthobiologics. It offers spine implants such …
  • Strand Life Sciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Strand Life Sciences Pvt Ltd (Strand Life) is a healthcare technology company that develops offers bioinformatics and clinical diagnostic software products. The company offers bioinformatics software for most analytics platforms such as microarrays, mass spectrometry, next generation sequenc …
  • Corcept Therapeutics Inc (CORT):企業の財務・戦略的SWOT分析
    Corcept Therapeutics Inc (CORT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Zagro Asia Ltd:企業の戦略的SWOT分析
    Zagro Asia Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Shell Pakistan Ltd (SHEL):企業の財務・戦略的SWOT分析
    Summary Shell Pakistan Ltd (Shell Pakistan), a subsidiary of Royal Dutch Shell plc is an oil and gas company that markets petroleum products and compressed natural gas. The company operates through three segments such as retail, lubricants and aviation. It retail segment offers a range of fuels such …
  • Deltex Medical Group Plc (DEMG):企業の財務・戦略的SWOT分析
    Summary Deltex Medical Group Plc (Deltex Medical), formerly Chalkgrove Plc, is a medical device company that develops fluid management equipment and oesophageal doppler monitoring systems. The company offers products such as cardioQ-ODM+, probes, simulator, bougies, cerebral oximetry, video laryngos …
  • Qiagen Marseille SA-医療機器分野:企業M&A・提携分析
    Summary Qiagen Marseille SA (HalioDx), formerly Ipsogen SA is a subsidiary of Qiagen NV, a drugs manufacturing company that develops and markets molecular diagnostic tests. The company offers products for the treatment of chronic myeloid, chronic lymphocytic, acute myeloid, and acute lymphoblastic l …
  • Helix Energy Solutions Group, Inc.:企業の戦略・SWOT・財務分析
    Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Helix Energy Solutions Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Hagoromo Foods Corp:企業の戦略・SWOT・財務分析
    Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Supernus Pharmaceuticals Inc (SUPN)-製薬・医療分野:企業M&A・提携分析
    Summary Supernus Pharmaceuticals Inc (Supernus) is a specialty pharmaceutical company which develops and commercializes products for the treatment of central nervous system (CNS) diseases. The company's neurology portfolio consists of Oxtellar XR (oxcarbazepine), an adjunct therapy for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆